September 2012 | Oncology & Biotech News

City of Hope: Boldly Traversing the "Valley of Death"

October 19, 2012

Founded in 1913 as a tuberculosis sanatorium, City of Hope today enjoys a reputation as a leading research, treatment, and education center for those with cancer, diabetes, and other life-threatening diseases.

Aprepitant Helps Prevent CINV in Men With Germ Cell Tumors

October 10, 2012

The addition of aprepitant to standard antiemetic prophylaxis significantly improved the complete response rate in patients with germ cell tumors undergoing 5-day cisplatin combination chemotherapy regimens.


September 25, 2012

A consortium of over 442 global investigators at 32 institutions recently reported results in over 30 publications of a decade of work from the Encyclopedia of DNA Elements project.